ARTICLE | Clinical News
CytoFab: Phase IIb started
November 1, 2010 7:00 AM UTC
AstraZeneca began a double-blind, placebo-controlled, international Phase IIb trial in 300 patients to evaluate 2 IV doses of CytoFab. Patients will receive a loading dose of 250 units/kg followed by ...